In the TCGA dataset, lower TOX expression was seen in MES and CL subtypes of GBM compared to NE and PN subtypes, while the distinction was conspicuous in pan-glioma analysis (Fig. 2c). The gene discussed is TOX; the disease is central nervous system cancer.